Margareta Hellgren

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 317 citations · Full text

Diabetes Management, Urology, Medicine +11

Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B

Anna Olsson, Margareta Hellgren, Erik Berntorp et al. · Blood Coagulation & Fibrinolysis · 2014 · 68 citations

Immunohematology, Pathology, Factor Level +17

Associations between serum insulin and homocysteine in a Swedish population—a potential link between the metabolic syndrome and hyperhomocysteinemia: The Skaraborg project

Joar Björck, Margareta Hellgren, Lennart Råstam et al. · Metabolism · 2006 · 57 citations

Metabolic Syndrome, Serum Insulin, Metabolic Disorder +10

Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross‐sectional population‐based study

Margareta Hellgren, Max Petzold, Cecilia Björkelund et al. · Diabetic Medicine · 2012 · 49 citations

Objectively Assessed Physical Activity and Weight Loss Maintenance among Individuals Enrolled in a Lifestyle Intervention

Jessica L. Unick, Sarah A. Gaussoin, James O. Hill et al. · Obesity · 2017 · 44 citations · Full text